podophyllotoxin has been researched along with Chromosomal Translocation in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardanaz, MT; Calasanz, MJ; Hernández, R; Lahortiga, I; Larráyoz, MJ; Novo, FJ; Odero, MD; Vázquez, I; Vizmanos, JL | 1 |
| Evans, J; George, R; Pearson, AD; Reid, MM | 1 |
| Rubinstein, L; Smith, MA; Ungerleider, RS | 1 |
| Bowman, WP; Croce, CM; Felix, CA; Lange, BJ; Negrini, M; Winick, NJ | 1 |
| Behm, FG; Bowman, LC; Head, DR; Heaton, D; Hurwitz, CA; Pui, CH; Raimondi, SC; Sandoval, C | 1 |
| Goto, T; Kozuru, M; Kumagawa, M; Muta, K; Suehiro, Y; Uike, N | 1 |
| Felix, CA | 1 |
| Head, D; Mathew, S; Raimondi, SC; Rubnitz, JE | 1 |
| Albain, KS; Le Beau, MM; Schumacher, H; Ullirsch, R | 1 |
3 review(s) available for podophyllotoxin and Chromosomal Translocation
| Article | Year |
|---|---|
Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
Topics: Alkylating Agents; Cell Cycle; Child; Chromosomes, Human, Pair 11; Clinical Trials as Topic; Drug Administration Schedule; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Lymphoma, Non-Hodgkin; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Risk Factors; Topoisomerase II Inhibitors; Translocation, Genetic | 1994 |
Secondary leukemias induced by topoisomerase-targeted drugs.
Topics: Antineoplastic Agents, Alkylating; Chromosome Breakage; DNA Damage; DNA-Binding Proteins; Genes, Neoplasm; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Podophyllotoxin; Proto-Oncogenes; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic | 1998 |
Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Iatrogenic Disease; Leukemia, Monocytic, Acute; Mastectomy, Radical; Middle Aged; Podophyllotoxin; Radiotherapy; Tamoxifen; Topoisomerase II Inhibitors; Translocation, Genetic | 1990 |
6 other study(ies) available for podophyllotoxin and Chromosomal Translocation
| Article | Year |
|---|---|
Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion.
Topics: Adult; Antineoplastic Agents, Phytogenic; Bone Marrow Transplantation; Chromosome Banding; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 8; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, Monocytic, Acute; Male; Oncogene Proteins, Fusion; Podophyllotoxin; Remission Induction; Translocation, Genetic | 2004 |
Secondary chronic myelomonocytic leukemia with t(9;11) in a child.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Female; Humans; Leukemia, Myelomonocytic, Chronic; Lymphoma, T-Cell; Neoplasms, Second Primary; Podophyllotoxin; Translocation, Genetic | 1994 |
Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.
Topics: Child, Preschool; Chromosomes, Human, Pair 11; DNA-Cytosine Methylases; DNA, Neoplasm; Etoposide; Humans; Leukemia, Monocytic, Acute; Male; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic | 1993 |
Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.
Topics: Acute Disease; Adolescent; Alkylating Agents; Antineoplastic Agents; Child; Combined Modality Therapy; Dactinomycin; Doxorubicin; Female; Humans; Intercalating Agents; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Podophyllotoxin; Radiotherapy; Topoisomerase II Inhibitors; Translocation, Genetic | 1993 |
Therapy-related acute myeloid leukemia with minimal myeloid differentiation (AML-M0) associated with a t(11;19)(q23;p13.3) translocation.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chromosomes, Human, Pair 11; Cyclophosphamide; DNA-Binding Proteins; Doxorubicin; Gene Rearrangement; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Myeloid-Lymphoid Leukemia Protein; Podophyllotoxin; Proto-Oncogenes; Transcription Factors; Translocation, Genetic; Vincristine; Zinc Fingers | 1997 |
Concurrent translocations of MLL and CBFA2 (AML1) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia.
Topics: Child, Preschool; Chromosome Breakage; Core Binding Factor Alpha 2 Subunit; DNA-Binding Proteins; Female; Histone-Lysine N-Methyltransferase; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins; Proto-Oncogenes; Transcription Factors; Translocation, Genetic | 2000 |